Acorah Software Products - Accounts Production19.2.350falsetruefalsetrueNo description of principal activity14 August 202431 August 202531 August 202515896561Dr Parth Desaiiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure158965612024-08-13158965612025-08-31158965612024-08-142025-08-3115896561frs-core:CurrentFinancialInstruments2025-08-3115896561frs-bus:PrivateLimitedCompanyLtd2024-08-142025-08-3115896561frs-bus:FilletedAccounts2024-08-142025-08-3115896561frs-bus:Micro-entities2024-08-142025-08-3115896561frs-bus:AuditExempt-NoAccountantsReport2024-08-142025-08-3115896561frs-bus:Director12024-08-142025-08-31
Registered number: 15896561
Flamingo Medical Ltd
Unaudited Financial Statements
For the Period 14 August 2024 to 31 August 2025
TaxAssist Accountants
Flamingo Medical Ltd
Balance Sheet
As At 31 August 2025
Balance Sheet
Registered number: 15896561
31 August 2025
£
Current assets
12,429
Creditors: Amounts Falling Due Within One Year
(2,186)
NET CURRENT ASSETS
10,243
TOTAL ASSETS LESS CURRENT LIABILITIES
10,243
Accruals and deferred income
(921)
NET ASSETS
9,322
CAPITAL AND RESERVES
9,322
Notes
1.General Information
Flamingo Medical Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15896561. The registered office is 20 Wenlock Road, London, N1 7GU.
2.Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.